Question 1

What is Mesalamine?

Accepted Answer

Mesalamine belongs to a class of medications known as aminosalicylates . It works by decreasing swelling and inflammation in the lining of the large intestine.

By reducing this inflammation, the medication helps to control symptoms and prevent them from returning.

Question 2

What is Mesalamine used for?

Accepted Answer

Mesalamine is used to treat ulcerative colitis .

Question 3

How does Mesalamine work?

Accepted Answer

Mechanism of Action

Mesalamine, also known as 5-aminosalicylic acid (5-ASA), is an anti-inflammatory drug. While the exact process is not fully understood, it is believed to work topically by coming into direct contact with the inflamed lining of the gastrointestinal tract.

The medication helps control inflammation through several possible actions:

Blocking inflammatory chemicals: It may inhibit the production of substances like prostaglandins and leukotrienes, which are known to cause swelling and tissue damage in the intestines.

Reducing oxidative stress: It may act as an antioxidant, helping to neutralize free radicals that contribute to inflammation.

By decreasing the inflammation in the colon and rectum, mesalamine helps reduce symptoms such as stomach pain, diarrhea, and rectal bleeding. It is used both to treat active flare-ups and to help maintain remission by preventing the inflammation from returning.

Question 4

What are the brand names for Mesalamine?

Accepted Answer

Mesalamine is sold under the brand names Asacol , Pentasa , and Lialda .

Question 5

What are the active ingredients in Mesalamine?

Accepted Answer

The active ingredient in Mesalamine is mesalamine .

Question 6

What are the side effects of Mesalamine?

Accepted Answer

Common side effects of Mesalamine may include:

headache

abdominal pain

diarrhea

and others

Always consult with a healthcare professional about potential side effects.

Question 7

What drug class is Mesalamine?

Accepted Answer

Mesalamine belongs to the 5-aminosalicylic acid derivative drug class.

Question 8

What is the dosage of Mesalamine and how do I take it?

Accepted Answer

Administration Methods

Mesalamine is available in several different forms, including oral tablets, capsules, and granules, as well as rectal suppositories and suspensions (enemas). The specific instructions for use depend on the formulation prescribed.

Oral Forms

Swallow Whole: Most oral tablets and capsules should be swallowed whole. Do not crush, chew, or break them, as they are designed to release the medication at a specific point in the intestines.

Granules: If you are using the granule form, follow the specific instructions provided with the medication. Usually, granules are placed on the tongue and swallowed with a drink without being chewed.

Food: Some oral products must be taken with food, while others can be taken with or without food. Refer to the specific instructions on your prescription label.

Rectal Forms

Timing: Rectal enemas and suppositories are typically used once daily at bedtime.

Preparation: For the best results, it is generally recommended to use rectal forms after a bowel movement.

Retention: These medications are meant to be held in the rectum for a specific amount of time to allow the drug to work. Follow the instructions provided with your specific product regarding how long to retain the dose.

Missed Dose

If you miss a dose, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and continue with your regular schedule. Do not take two doses at the same time to make up for a missed one.

Question 9

Is Mesalamine safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Mesalamine is known to cross the placental barrier. While animal studies using high doses have not shown a significant risk of harm to the fetus, there are limited well-controlled studies in pregnant humans. Because animal reproduction studies are not always predictive of human response, mesalamine should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

Breastfeeding

Mesalamine and its primary metabolite are excreted in human breast milk. There have been reports of diarrhea in infants who are breastfed by individuals taking mesalamine. If you are breastfeeding or planning to breastfeed, it is important to discuss the risks and benefits with your healthcare provider. If you continue to use this medication while breastfeeding, monitor your infant closely for changes in bowel movements, such as diarrhea.

Question 10

What forms and strengths does Mesalamine come in?

Accepted Answer

Oral Formulations

Mesalamine is commonly taken by mouth in forms designed to bypass the stomach and release the medication in the intestines. These include:

Delayed-release tablets

Delayed-release capsules

Extended-release capsules

Rectal Formulations

For inflammation located in the lower part of the colon or rectum, mesalamine may be administered rectally. These forms include:

Rectal suppositories

Rectal suspension (enema)

The specific form prescribed often depends on the location and severity of the inflammation within the digestive system.

Question 11

What is the FDA approval status of Mesalamine?

Accepted Answer

FDA Approval and Indications

Mesalamine is approved by the U.S. Food and Drug Administration (FDA) for the treatment of mildly to moderately active ulcerative colitis. It is also indicated for the maintenance of remission in patients with ulcerative colitis. The specific approved uses and age groups may vary depending on the formulation and the manufacturer.

Approved Formulations

The FDA has approved mesalamine in several delivery formats to target inflammation in different areas of the gastrointestinal tract:

Oral formulations: These include delayed-release tablets, delayed-release capsules, and extended-release capsules.

Rectal formulations: These include suppositories and rectal suspensions (enemas).

Safety and Regulatory Monitoring

Mesalamine does not currently have any boxed warnings or Risk Evaluation and Mitigation Strategies (REMS) requirements. However, the FDA requires labeling to include warnings regarding the risk of renal impairment. Healthcare providers are generally advised to assess kidney function before starting treatment and periodically during therapy. Other regulatory warnings include mesalamine-induced acute intolerance syndrome, which can cause symptoms similar to an ulcerative colitis flare, and potential hypersensitivity reactions.

Question 12

What should I know about Mesalamine and cost?

Accepted Answer

Formulation and Pricing

Mesalamine is available in several different forms, including oral delayed-release tablets, extended-release capsules, rectal suppositories, and rectal enemas. The price often depends on the specific delivery system required for the condition. Oral formulations designed for targeted release in the colon may have different price points than rectal applications.

Generic Availability

Generic versions are available for many mesalamine products, such as those equivalent to Lialda or Canasa. Opting for a generic version typically reduces the out-of-pocket expense. However, not all brand-name formulations have a generic equivalent, and some newer or specialized delivery systems may only be available as higher-priced brand-name drugs.

Insurance and Assistance

Most health insurance plans and Medicare Part D provide coverage for mesalamine, though the specific cost to the patient depends on the plan's formulary. Generic versions are usually placed in lower-cost tiers with smaller copayments. For patients without insurance or those with high deductibles, some manufacturers offer savings cards or patient assistance programs for brand-name products.

Mesalamine

Medication Quick Facts

📋Overview

What It's Used For

How It Works

Brand Names

Side Effects

Warnings & Precautions

Dosage & How to Take

Pregnancy & Breastfeeding

Forms & Strengths

FDA / Regulatory Status

Price Information

FAQ

Additional Resources

Support & Help Resources

Found an Error?